The DOI matches its Crossref record.
Contemporary management of ischemic priapism: A 12‐year population‐based analysis from a large US database
Abstract
Background: Priapism is a urological condition characterized by a persistent erection. The management varies based on its subclassifications. Despite established clinical guidelines for ischemic priapism, there is a lack of large‐scale research focused on patient characteristics and management strategies. Objectives: To analyze the contemporary management of ischemic priapism in the US, exploring patient demographics and clinical characteristics, as well as predictors of erectile dysfunction (ED) and penile prosthesis implantation (PPI). Materials and methods: We performed a retrospective analysis of the PearlDiver Mariner database, reviewing records from 2010–2021. Adult males diagnosed with ischemic priapism were included. Data analysis covered demographic, clinical variables, and management strategies. Predictors of de novo ED and PPI were evaluated using multivariable logistic regression analysis. Results: Of 36,120 patients, most (93%) received only medical management, and a minority underwent surgical interventions (penile shunt surgery [PSS], PPI or both). Medical management was typically effective, as 67.08% of the patients in this group experienced only one episode of priapism. However, de novo ED occurred in 16.57% of these patients. The majority of patients undergoing PPI had an inflatable prosthesis (81%). Older age (odds ratio, OR 1.02), the presence of metabolic diseases (OR 1.39), neurogenic disorders (OR 1.72), solid pelvic malignancies (OR 1.09), and multiple episodes of priapism were identified as significant predictors of de novo ED (all p < 0.05). Similarly, age (OR 1.03), the presence of metabolic diseases (OR 1.23), solid pelvic malignancies (OR 1.99), and multiple episodes of priapism were associated with higher likelihood of PPI (all p < 0.05). Conclusion: Most cases of ischemic priapism are managed with the medical therapy. Less than 3% of patients with ischemic priapism receive PPI, and when this occurs an inflatable prosthesis is favored. Age, specific comorbidities, and multiple episodes of priapism appear to be significant predictors of ED and PPI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This condition constitutes a urological emergency necessitating prompt diagnosis and intervention to prevent long-term sequelae including erectile dysfunction and penile fibrosis [1, 2].”
From Chlorpromazine-tadalafil interaction leading to refractory ischemic priapism and penile prosthesis implantation: a case report (2025) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 32
- SaloniaA BettocchiC CarvalhoJ CoronaG JonesTH KadiogluA.European Association of Urology Guidelines on Sexual and Reproductive Health.2023. Accessed February 2024.https://uroweb.org/guidelines/sexual‐and‐reproductive‐health/chapter/priapism
- 10.1002/smrj.37 · DOI
- 10.1097/JU.0000000000002767 · DOI
- Khan QS, 2016, Priapism: what cause: mental illness, psychotropic medications or poly‐substance abuse?, J Okla State Med Assoc, 109, 515
- 10.1155/2019/6214921 · DOI
- 10.1001/jama.2022.10233 · DOI · Paper page
- 10.1016/S0022‐5347(17)45549‐2 · DOI
- 10.1016/j.urology.2021.03.063 · DOI
- 10.1182/hematology.2022000380 · DOI
- 10.1097/00005650‐199801000‐00004 · DOI · Paper page
- 10.1016/j.eururo.2013.11.008 · DOI
- 10.1111/bju.15370 · DOI
- 10.5152/tud.2023.22209 · DOI
- 10.1038/s41443‐024‐00928‐0 · DOI
- 10.3390/app11157090 · DOI
- 10.1590/s1677‐5538.ibju.2020.s125 · DOI
- 10.2147/RRU.S278807 · DOI
- 10.1016/j.sxmr.2017.08.002 · DOI
- 10.21037/tau‐23‐224 · DOI
- 10.1093/jsxmed/qdad075 · DOI
- 10.1038/s41443‐021‐00518‐4 · DOI
- 10.1097/JU.0000000000001183 · DOI
- 10.1111/jsm.12816 · DOI
- 10.1177/1756287217717913 · DOI
- 10.1111/j.1743‐6109.2009.01665.x · DOI
- 10.1007/s10545‐017‐0107‐6 · DOI
- 10.18632/oncotarget.23366 · DOI
- 10.1038/s41443‐019‐0141‐z · DOI
- 10.4081/aiua.2016.2.150 · DOI
- 10.3390/diseases11010034 · DOI
- 10.1016/j.sxmr.2018.10.002 · DOI
- 10.3390/jcm12072697 · DOI
Cited by
Arici, C., Basaranoglu, M., Cayan, S., Bozlu, M., & Akbay, E. (2025) · Basic and Clinical Andrology · doi:10.1186/s12610-025-00278-x
Metadata
- Authors
- Licari, L. C., Bologna, E., Ditonno, F., Franco, A., Lasorsa, F., Bignante, G., Proietti, F., Leonardo, C., Anele, U. A., Cherullo, E. E., Levine, L. A., Autorino, R., & Manfredi, C.
- Venue
- Andrology
- Publisher
- Wiley
- Published
- 2024-08-14
- Volume
- 13
- Issue
- 4
- Pages
- 811-820
- ISSN
- 2047-2919
- 2047-2927
- Cited by
- 5
- References
- 0
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.